← Leaderboards
Douglas Allen Corley
University Of California San Francisco
$15,364,838
Attributed
$32,904,459
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$42,468,770 · 13
By mechanism
UM1$15,638,716 · 1
U54$14,195,895 · 4
R01$10,737,217 · 4
R56$767,193 · 1
K08$599,130 · 1
R21$405,151 · 1
Top collaborators
- Chyke Abadama Doubeni18 shared
- Joanne E Schottinger7 shared
- Ann Graham Zauber7 shared
- Jessica Chubak6 shared
- Ethan A Halm6 shared
- Celette Sugg Skinner6 shared
- Richard Bernard Hayes5 shared
- Aruna Kamineni5 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Matthias Hebrok$19,978,612
- Zena Werb$33,582,689
- Kevin M Shannon$44,683,939
- Maria L Ekstrand$16,093,949
- Douglas Hanahan$19,892,030
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCommunitiesColorectal CancerBaseCessation Of LifeResourcesColorectal Cancer ScreeningColonoscopyDiagnosisScreeningCancer RiskPatternMemberCollaborationsPersonsCohortIncidenceCaliforniaEffectivenessAdenomaPhysiciansScientistHealthcarePublishing
Grant awards (62)
Addressing Disparities in Outcomes of Screening for Colorectal Cancer in Community-Based Settings$671,512
R01 · FY2025 · CA
Advancing Access in Cancer Care: Investigating Health-Related Social Needs and Colonoscopy Follow-Up Among FQHC Patients$206,287
R01 · FY2025 · CA
Addressing Disparities in Outcomes of Screening for Colorectal Cancer in Community-Based Settings$637,940
R01 · FY2024 · CA
Advancing Equity in Cancer Care: Investigating Health- Related Social Needs and Colonoscopy Follow-Up Among FQHC Patients$206,287
R01 · FY2024 · CA
Addressing Disparities in Outcomes of Screening for Colorectal Cancer in Community-Based Settings$700,356
R01 · FY2023 · CA
Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)$564,678
UM1 · FY2023 · CA · contact PI
Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)$2,977,848
UM1 · FY2022 · CA · contact PI
Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)$2,565,829
UM1 · FY2021 · CA · contact PI
Effectiveness of screening for colorectal cancer in average risk adults: Colonoscopy vs FIT$490,729
R01 · FY2021 · CA
Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)$3,149,821
UM1 · FY2020 · CA · contact PI
Effectiveness of screening for colorectal cancer in average risk adults: Colonoscopy vs FIT$599,148
R01 · FY2020 · CA
Comprehensive Colorectal Cancer Risk Prediction to Inform Personalized Screening$518,658
R01 · FY2020 · CA
Effectiveness of screening for colorectal cancer in average risk adults: Colonoscopy vs FIT$381,594
R01 · FY2020 · CA
Comprehensive Colorectal Cancer Risk Prediction to Inform Personalized Screening$99,127
R01 · FY2020 · CA
Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)$3,116,337
UM1 · FY2019 · CA · contact PI
Comprehensive Colorectal Cancer Risk Prediction to Inform Personalized Screening$628,904
R01 · FY2019 · CA
Effectiveness of screening for colorectal cancer in average risk adults: Colonoscopy vs. FIT$245,046
R01 · FY2019 · CA
Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)$3,264,203
UM1 · FY2018 · CA · contact PI
Comprehensive Colorectal Cancer Risk Prediction to Inform Personalized Screening$674,450
R01 · FY2018 · CA
Effectiveness of screening for colorectal cancer in average risk adults: Colonoscopy vs. FIT$657,495
R01 · FY2018 · CA
Comprehensive Colorectal Cancer Risk Prediction to Inform Personalized Screening$738,377
R01 · FY2017 · CA
Effectiveness of screening for colorectal cancer in average risk adults: Colonoscopy vs. FIT$709,946
R01 · FY2017 · CA
Optimizing Colonoscopy & Fecal Immunochemical Tests for Community-Based Screening$700,000
U54 · FY2017 · CA · contact PI
Optimizing Colonoscopy & Fecal Immunochemical Tests for Community-Based Screening$1,668,673
U54 · FY2015 · CA · contact PI
Optimizing Colonoscopy & Fecal Immunochemical Tests for Community-Based Screening$648,413
U54 · FY2015 · CA · contact PI
Optimizing the use of colonoscopy for CRC screening in a large community-based$524,272
U54 · FY2015 · CA · contact PI
CORES$371,527
U54 · FY2015 · CA · contact PI
BIOSTATISTICS$309,613
U54 · FY2015 · CA · contact PI
Optimizing Colonoscopy & Fecal Immunochemical Tests for Community-Based Screening$1,659,426
U54 · FY2014 · CA · contact PI
Optimizing Colonscopy & Fecal Immunochemical Tests for Community-Based Screening$649,992
U54 · FY2014 · CA · contact PI
Optimizing the use of colonoscopy for CRC screening in a large community-based$608,278
U54 · FY2014 · CA · contact PI
CORES$350,270
U54 · FY2014 · CA · contact PI
BIOSTATISTICS$311,900
U54 · FY2014 · CA · contact PI
Optimizing Colonoscopy & Fecal Immunochemical Tests for Community-Based Screening$1,498,297
U54 · FY2013 · CA · contact PI
Optimizing the use of colonoscopy for CRC screening in a large community-based$584,888
U54 · FY2013 · CA · contact PI
CORES$394,461
U54 · FY2013 · CA · contact PI
BIOSTATISTICS$383,806
U54 · FY2013 · CA · contact PI
Optimizing Colonoscopy & Fecal Immunochemical Tests for Community-Based Screening$1,141,762
U54 · FY2012 · CA · contact PI
Optimizing the use of colonoscopy for CRC screening in a large community-based$323,070
U54 · FY2012 · CA · contact PI
BIOSTATISTICS$249,133
U54 · FY2012 · CA · contact PI
CORES$220,366
U54 · FY2012 · CA · contact PI
Optimizing Colonoscopy & Fecal Immunochemical Tests for Community-Based Screening$1,597,748
U54 · FY2011 · CA · contact PI
Adipokines and Barrett's Esophagus$767,193
R56 · FY2010 · DK · contact PI
Epidemiology and Incidence of Barrett's Esophagus$240,395
R01 · FY2010 · DK · contact PI
Epidemiology and Incidence of Barrett's Esophagus$253,643
R01 · FY2009 · DK · contact PI
Barrett's Esophagus: Risk Factors in Women$185,027
R21 · FY2009 · DK · contact PI
Epidemiology and Incidence of Barrett's Esophagus$382,453
R01 · FY2008 · DK · contact PI
Barrett's Esophagus: Risk Factors in Women$220,124
R21 · FY2008 · DK · contact PI
Epidemiology and Incidence of Barrett's Esophagus$298,240
R01 · FY2006 · DK · contact PI
Epidemiology and Incidence of Barrett's Esophagus$306,622
R01 · FY2005 · DK
Epidemiology and Incidence of Barrett's Esophagus$343,830
R01 · FY2004 · DK
ETIOLOGIES/SURVEILLANCE OF BARRETT'S ESOPHAGUS$121,770
K08 · FY2004 · DK
Epidemiology and Incidence of Barrett's Esophagus$373,089
R01 · FY2003 · DK
ETIOLOGIES/SURVEILLANCE OF BARRETT'S ESOPHAGUS$121,770
K08 · FY2003 · DK
ETIOLOGIES/SURVEILLANCE OF BARRETT'S ESOPHAGUS$1,080
K08 · FY2003 · DK
Epidemiology and Incidence of Barrett's Esophagus$373,089
R01 · FY2002 · DK
ETIOLOGIES/SURVEILLANCE OF BARRETT'S ESOPHAGUS$121,770
K08 · FY2002 · DK
ETIOLOGIES/SURVEILLANCE OF BARRETT'S ESOPHAGUS$116,370
K08 · FY2001 · DK
EVALUATION OF RISK FACTORS FOR BARRETT'S ESOPHAGUS$34,276
R03 · FY2001 · DK
EVALUATION OF RISK FACTORS FOR BARRETT'S ESOPHAGUS$22,365
R03 · FY2001 · DK
ETIOLOGIES/SURVEILLANCE OF BARRETT'S ESOPHAGUS$116,370
K08 · FY2000 · DK
EVALUATION OF RISK FACTORS FOR BARRETT'S ESOPHAGUS$68,827
R03 · FY2000 · DK